Re: SF
|
4
|
Resverlogix Corp.
|
Sep 17, 2020 01:57PM
|
For the sake of the argument...
|
5
|
Resverlogix Corp.
|
Sep 27, 2020 10:48PM
|
Re: Monday
|
14
|
Resverlogix Corp.
|
Oct 01, 2020 07:33PM
|
Re: Resverlogix Confirms Interim Filings on SEDAR
|
8
|
Resverlogix Corp.
|
Oct 04, 2020 01:18PM
|
Re: Resverlogix Announces $13 Million Private Placement
|
5
|
Resverlogix Corp.
|
Oct 06, 2020 03:51PM
|
Re: Resverlogix Announces $13 Million Private Placement
|
9
|
Resverlogix Corp.
|
Oct 07, 2020 12:40PM
|
Re: December 22, 2020.wideout
|
10
|
Resverlogix Corp.
|
Oct 10, 2020 03:22PM
|
Re: Resverlogix Announces Conversion of US$12 Million Debenture Strengthening Balance Sheet
|
2
|
Resverlogix Corp.
|
Oct 14, 2020 11:07AM
|
Re: Leading From Behind
|
5
|
Resverlogix Corp.
|
Oct 14, 2020 01:04PM
|
ORI
|
11
|
Resverlogix Corp.
|
Oct 15, 2020 06:44PM
|
Re: The problem...as I see it
|
12
|
Resverlogix Corp.
|
Oct 17, 2020 12:20AM
|
Re: The problem...as I see it
|
14
|
Resverlogix Corp.
|
Oct 17, 2020 05:32PM
|
Hepa / ORI
|
5
|
Resverlogix Corp.
|
Oct 30, 2020 11:13AM
|
Something brewing?
|
8
|
Resverlogix Corp.
|
Jan 25, 2021 02:29PM
|
Short position
|
|
Resverlogix Corp.
|
Jan 29, 2021 01:08AM
|
Good grief
|
4
|
Resverlogix Corp.
|
Feb 04, 2021 11:51AM
|
Sneaking Suspicion...
|
6
|
Resverlogix Corp.
|
Feb 04, 2021 12:00PM
|
Re: Apabetalone treatment reduces SARS-CoV-2 infectivity and completely prevents cardiac damage in a cytokine-storm model
|
2
|
Resverlogix Corp.
|
Mar 03, 2021 06:25PM
|
Volume
|
2
|
Resverlogix Corp.
|
Mar 15, 2021 11:04AM
|
Re: The cardiac pre-print now published....in Cell!
|
5
|
Resverlogix Corp.
|
Mar 16, 2021 03:21PM
|